Could a psychoactive compound curb alcohol cravings? new trial launches
Disease control
Recruiting now
This study is testing a new drug called CMND-100 (MEAI) in healthy volunteers and people with alcohol use disorder. The goal is to find a safe dose and see if it can reduce drinking and cravings. The trial is currently recruiting 84 participants.
Phase: PHASE1, PHASE2 • Sponsor: Clearmind Medicine Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC